C4X Discovery Holdings PLC (LSE:C4XD) - Share price


Stock Report

C4X Discovery Holdings PLC C4XD

Last Price
GBX31.75

Day Change
-0.50|-1.55%

As of 27/09/2021
16:20:47 BST | GBX
Minimum 15 Minutes Delay.

Last Close32.25p
Day Range31.50 - 32.00
Mkt Cap73.47Mil
52-Wk Range10.10 - 54.50
Yield %-
ISINGB00BQQ2RV18
Volume74,936
P/E-
P/SInfinity
P/CF-0.06

Share Price

Total Returns 24/09/2021

 Chg (%)  
More ...
C4X Discovery Holdings PLC9.32 
FTSE 100 TR GBP-0.74
 
Financials
201820192020
More ...
Income Statement
Turnover7.060.000.00
Operating Profit-2.53-13.64-9.57
Net Profit-1.14-10.91-7.79
Reported EPS-2.34-18.82-8.10
Balance Sheet
Current Assets7.337.107.87
Non Current Assets1.711.571.77
Total Assets9.048.679.64
Current Liabilities0.871.651.36
Total Liabilities---
Total Equity8.177.018.07
Cash Flow
Operating Cash Flow-2.14-12.69-9.16
Net Change in Cash-0.45-3.203.27

Company Profile

C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 10/12/2021

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-115.42
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Financial OfficerMr. Bradley Richard Hoy
Non-Executive DirectorDr. Alexander James Stevenson
Executive Director, Chief Executive OfficerDr. Clive James Dix
Non-Executive DirectorMr. Harry Finch
Executive Director, Chief Scientific OfficerDr. Justian Craig Fox
Non-Executive DirectorMs. Natalie Louise Walter
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.